MLT ASCP PRACTICE TEST QUESTIONS BOARD PRACTICE EXAM NEWEST 2026/ 2027 ACTUAL EXAM TEST BANK| MEDICAL LABORATORY TECHNICIAN EXAM PREP WITH COMPLETE 100 REAL EXAM QUESTIONS AND CORRECT DETAILED ANSWERS (VERIFIED ANSWERS) ALREADY GRADED A+ (MOST RE

MLT ASCP PRACTICE TEST
QUESTIONS BOARD PRACTICE EXAM
NEWEST 2026/ 2027 ACTUAL EXAM
TEST BANK| MEDICAL LABORATORY
TECHNICIAN EXAM PREP WITH
COMPLETE 100 REAL EXAM
QUESTIONS AND CORRECT
DETAILED ANSWERS (VERIFIED
ANSWERS) ALREADY GRADED A+
(MOST RECENT!!)
B;

ThemCORRECTmANSWERmformthismquestionmism1300mmg/dL.mThemlaboratorianmperformedmam1:4mdi
lutionmbymaddingm0.25mmLm(orm250mmicroliters)mofmpatientmsamplemtom750mmicrolitersmofmdiluent.
mThismcreatesmamtotalmvolumemofm1000mmicroliters.mSo,mthempatientmsamplemism250mmicrolitersmofm


them1000mmicrolitermmixedmsample,mormamratiomofm1:4.mTherefore,mthemresultmgivenmbymthemchemi
strymanalyzermmustmbemmultipliedmbymamdilutionmfactormofm4.m325mmg/dLmxm4m=m1300mmg/dL.m-
mCORRECTmANSWERmAftermexperiencingmextrememfatiguemandmpolyuria,mampatient'smbasicmmetab


olicmpanelmismanalyzedminmthemlaboratory.mThemresultmofmthemglucosemismtoomhighmformtheminstrume
ntmtomread.mThemlaboratorianmperformsmamdilutionmusingm0.25mmLmofmpatientmsamplemtom750mmicr
olitersmofmdiluent.mThemresultmnowmreadsm325mmg/dL.mHowmshouldmthemtechologistmreportmthismp
atient'smglucosemresult?



A.m325mmg/dL

B.m1300mmg/dL

C.m975mmg/dL

D.m1625mmg/dL

,A;

ConversionmofmonlymthemslantmtomampinkmcolorminmamChristensen'smureamagarmslantmismproducedmby
mbacterialmspeciesmthatmhavemweakmureasemactivity.mThemreactionminmthemslantmtomthemrightmismofte


nmproducedmbymKlebsiellamspecies,masmanmexample.mStrongmureasemactivitymismindicatedmbymconve
rsionmofmthemslantmandmthembuttmofmthemtubemtomampinkmcolor,masmseenminmthemtubemtomthemleft.mTh
emslantmonlymreactionminmthemrightmtubemmaymbemseenmearlymonmifmonlymthemslantmhadmbeenminocu
lated;mhowever,mwithmamstrongmureasemproducer,mbothmthemslantmandmthembuttmwouldmturn.mTher
efore,mthemreactionmismdependentmonmthemstrengthmofmureasemactivity.mIfmthemmediamhadmoutdate
dmformamprolongedmperiod,meithermtheremwouldmbemnomreactionmormthemappearancemofmonlymamfain
tmpinkmtinge,meitherminmthemslant,mthembuttmormboth,magainmdependingmonmthemstrengthmofmurease
mproductionmbymthemunknownmorganism.m-


mCORRECTmANSWERmThemureasemreactionmseenminmthemChristensen'smureamagarmslantmonmthemfarm


rightmindicates:



A.mWeakmactivity

B.mStrongmactivity

C.mSlantmonlyminoculated

D.mUsemofmoutdatedmmedium



D;

ThemstepsminmthemPCRmprocessmare:

1.mDenaturationm(TurningmdoublemstrandedmDNAmintomsinglemstrands.)

2.mAnnealing/Hybrizationm(AttachmentmofmprimersmtomthemsinglemDNAmstrands.)

3.mExtensionm(CreatingmthemcomplementarymstrandmtomproducemnewmdoublemstrandedmDNA.)m-
mCORRECTmANSWERmWhatmismthemfirstmstepmofmthemPCRmreaction?




A.mHybridization

B.mExtension

C.mAnnealing

D.mDenaturation

,B;

Isotonicmormnormalmsalinemismam0.85m%msolutionmofmsodiummchlorideminmwater.m-
mCORRECTmANSWERmThemconcentrationmofmsodiummchlorideminmanmisotonicmsolutionmism:




A.m8.5m%

B.m0.85m%

C.m0.08m%

D.m1mmolar



C;

InmDIC,mormdisseminatedmintravascularmcoagulation,mthemprothrombinmtimemismincreasedmduemtomt
hemconsumptionmofmthemcoagulationmfactorsmduemtomthemtinymclotsmformingmthroughoutmthemvasc
ulature.mThismismalsomthemreasonmthatmthemfibrinogenmlevelsmandmplateletmlevelsmaremdecreased.mFi
nallymFDP,mormfibrinmdegredationmproducts,maremincreasedmduemtomthemformationmandmsubsequen
tmdissolvingmofmmanymtinymclotsminmthemvasculature.mThemFDPsmaremthempiecesmofmfibrinmthatmareml
eftmaftermthemfibrinolyticmprocessesmtakemplace.m-
mCORRECTmANSWERmWhichmofmthemfollowingmlaboratorymresultsmwouldmbemseenminmampatientmwit


hmacutemDisseminatedmIntravascularmCoagulationm(DIC)?



A.mprolongedmPT,melevatedmplateletmcount,mdecreasedmFDP

B.mnormalmPT,mdecreasedmfibrinogen,mdecreasedmplateletmcount,mdecreasedmFDP

C.mprolongedmPT,mdecreasedmfibrinogen,mdecreasedmplateletmcount,mincreasedmFDP

D.mnormalmPT,mdecreasedmplateletmcount,mdecreasedmFDP



B;

Amdilutionmcommonlymusedmformamroutinemspermmcountmismam1:20.m-
mCORRECTmANSWERmAmdilutionmcommonlymusedmformamroutinemspermmcountmis:

, A.m1:2

B.m1:20

C.m1:200

D.m1:400



B;

Prozonemeffectm(duemtomantibodymexcess)mwillmresultminmanminitialmfalsemnegativeminmspitemofmtheml
argemamountmofmantibodyminmthemserum,mfollowedmbymampositivemresultmasmthemspecimenmismdilut
ed.m-
mCORRECTmANSWERmThemprozonemeffectm(mwhenmperformingmamscreeningmtiter)mismmostmlikelymto


mresultmin:




A.mFalsempositive

B.mFalsemnegative

C.mNomreactionmatmall

D.mMixedmfieldmreaction



A;

OnemofmthemkeymcharacteristicsmtomthemidentificationmofmNocardiamasteroidesmismitsminabilitymtomhy
drolyzemcasein,mtyrosinemormxanthine,masmshownminmthismphotograph.mNitratesmaremreducedmtomnit
rites.mBothmNocardiambrasiliensismandmActinomadurammaduraemhydrolyzembothmcaseinmandmtyrosi
ne;mStreptomycesmgriseusmhydrolyzesmallmthreemofmthemsubstrates.m-
mCORRECTmANSWERmIllustratedminmthismphotographmismanmagarmquadrantmplatemcontainingmcasein


m(A),mtyrosinem(B),mnitratem(C)mandmxanthinem(D).mNonemofmthemsubstratesmhavembeenmhydrolyzedm


andmnitratemhasmbeenmreduced.mThemmostmlikelymidentificationmis:



A.mNocardiamasteroides

B.mNocardiambrasiliensis

C.mStreptomycesmgriseus